Response to: ‘Correspondence on ‘Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naive, early rheumatoid arthritis’’ by Georgiadis et al

Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

BMC Musculoskeletal Disorders ◽

10.1186/s12891-015-0587-1 ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 20

Author(s):

Mahmood M. T. M. Ally ◽

Bridget Hodkinson ◽

Pieter W. A. Meyer ◽

Eustasius Musenge ◽

Gregory R. Tintinger ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Early Rheumatoid Arthritis ◽

Antirheumatic Drug ◽

Disease Modifying ◽

Citrullinated Peptide ◽

Disease Modifying Antirheumatic Drug ◽

Peptide Antibodies

Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

Arthritis & Rheumatism ◽

10.1002/art.10135 ◽

2002 ◽

Vol 46 (4) ◽

pp. 894-898 ◽

Cited By ~ 268

Author(s):

Timo Möttönen ◽

Pekka Hannonen ◽

Markku Korpela ◽

Martti Nissilä ◽

Hannu Kautiainen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Early Rheumatoid Arthritis ◽

Antirheumatic Drug ◽

Single Drug ◽

Disease Modifying ◽

Correlation between serum methotrexate concentrations and disease remission status in rheumatoid arthritis patients on triple disease-modifying antirheumatic drug therapy

Indian Journal of Pharmacology ◽

10.4103/0253-7613.32532 ◽

2007 ◽

Vol 39 (2) ◽

pp. 117 ◽

Cited By ~ 1

Author(s):

Prasanna KumarT Subbanna ◽

SujithJ Chandy ◽

Debashish Danda ◽

BinuS Mathew

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Antirheumatic Drug ◽

Disease Remission ◽

Remission Status ◽

Disease Modifying ◽

Association of Dysregulated Central Pain Processing and Response to Disease–Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis

Arthritis & Rheumatology ◽

10.1002/art.41440 ◽

2020 ◽

Vol 72 (12) ◽

pp. 2017-2024

Author(s):

Andrew C. Heisler ◽

Jing Song ◽

Lutfiyya N. Muhammad ◽

Alyssa Wohlfahrt ◽

Wendy Marder ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Antirheumatic Drug ◽

Pain Processing ◽

Central Pain ◽

Disease Modifying ◽

Central Pain Processing ◽

Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis

Current Opinion in Rheumatology ◽

10.1097/bor.0000000000000378 ◽

2017 ◽

Vol 29 (3) ◽

pp. 277-284 ◽

Cited By ~ 7

Author(s):

Elena Myasoedova

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Antirheumatic Drug ◽

Disease Modifying ◽

Occurrence of Rheumatoid Arthritis Requiring Oral and/or Biological Disease-Modifying Antirheumatic Drug Therapy Following a Diagnosis of Primary Sjögren Syndrome

JCR Journal of Clinical Rheumatology ◽

10.1097/rhu.0b013e31826d2abb ◽

2012 ◽

Vol 18 (7) ◽

pp. 356-358 ◽

Cited By ~ 6

Author(s):

Omar Khan ◽

Steven Carsons

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Sjögren Syndrome ◽

Antirheumatic Drug ◽

Sjogren Syndrome ◽

Primary Sjögren Syndrome ◽

Disease Modifying ◽

Overview of Combination Second-Line or Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/xxxiv.suppl_4.96 ◽

1995 ◽

Vol XXXIV (suppl 4) ◽

pp. 96-99

Author(s):

H. J. Williams

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Antirheumatic Drug ◽

Second Line ◽

Disease Modifying ◽

Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy

Arthritis & Rheumatism ◽

10.1002/1529-0131(200008)13:4<213::aid-anr6>3.0.co;2-2 ◽

2000 ◽

Vol 13 (4) ◽

pp. 213-226 ◽

Cited By ~ 7

Author(s):

Robert I. Griffiths ◽

Miriam Bar-Din ◽

Catherine H. MacLean ◽

Erin M. Sullivan ◽

Robert J. Herbert ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Resource Use ◽

Antirheumatic Drug ◽

Medical Resource ◽

Disease Modifying ◽

Overview of Combination Second-Line or Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/xxxiv.suppl_2.96 ◽

1995 ◽

Vol XXXIV (suppl 2) ◽

pp. 96-99 ◽

Cited By ~ 3

Author(s):

H. J. Williams

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Antirheumatic Drug ◽

Second Line ◽

Disease Modifying ◽

Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy

JAMA ◽

10.1001/jama.2019.9055 ◽

2019 ◽

Vol 322 (4) ◽

pp. 315 ◽

Cited By ~ 43

Author(s):

Mark C. Genovese ◽

Kenneth Kalunian ◽

Jacques-Eric Gottenberg ◽

Neelufar Mozaffarian ◽

Beatrix Bartok ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Drug Therapy ◽

Clinical Response ◽

Antirheumatic Drug ◽

Severe Rheumatoid Arthritis ◽

Disease Modifying ◽